Advertisement

Picture Demy-Colton BioFuture 2021 NYC C Virtual Option 650x80px
Organisation › Details

BenevolentAI (Group)

BenevolentAI, founded in 2013, creates and applies AI and machine learning to transform the way medicines are discovered and developed. Benevolent integrates its technology into every step of the drug discovery process from hypothesis generation to late-stage clinical development. The Benevolent Platform® used by over 200 BenevolentAI scientists and technologists ingests molecular, clinical, pharmacological data and scientific literature, to derive contextual relationships across all relevant biomedical entities leading to the proposal of novel and optimal drug targets. The Platform supports scientists in the design and optimisation of the right drug molecule for a unique patient population. BenevolentAI is headquartered in London with a research facility in Cambridge (UK) and further offices in New York. BenevolentAI has active R&D drug programmes in disease areas such as ALS, Parkinson’s, Ulcerative Colitis and Sarcopenia. *

 

Period Start 2013-01-01 established
Products Industry artificial intelligence (AI) / machine learning (ML)
  Industry 2 LIFE SCIENCES
Persons Person Shields, Joanna (BenevolentAI 201909 CEO)
  Person 2 Mulvany, Kenneth (Proximagen 201111 CEO)
     
Region Region London, Greater London
  Country United Kingdom (GB)
  Street 4–8 Maple Street
  City W1T 5HD London
  Tel +44-20-37819-360
    Address record changed: 2020-12-02
     
Basic data Employees D: 101 to 500 (2018-04-19)
     
    * Document for �About Section�: BenevolentAI Ltd.. (9/17/19). "Press Release: BenevolentAI Announces $90 Million Investment from Temasek". London.
     
   
Record changed: 2021-06-05

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for BenevolentAI (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC A October 650x80px




» top